SCNT – Susan Solomon and Dr. Dieter Egli Discuss NYSCF’s Latest Breakthrough
Video
Dr. Dieter Egli, NYSCF Senior Research Fellow, discusses his latest somatic cell nuclear transfer (SCNT) research with NYSCF CEO Susan L. Solomon.
Dr. Dieter Egli, NYSCF Senior Research Fellow, discusses his latest somatic cell nuclear transfer (SCNT) research with NYSCF CEO Susan L. Solomon. This research, published in Nature, describes the first-ever human stem cell line derived from a patient, in this case a type 1 diabetic, using SCNT. In Addition, the scientists were able to turn these stem cells into insulin-producing beta cells, the cells lost in type 1 diabetes. Dr. Egli and Ms. Solomon discuss this breakthrough, next steps, and further research needed and its potential as a future cell therapy for the treatment of diabetes and other diseases.